152 related articles for article (PubMed ID: 38108171)
21. [Clinical features of pathologically confirmed metastatic bone tumors--a report of 390 cases].
Xu DL; Zhang XT; Wang GH; Li FB; Hu JY
Ai Zheng; 2005 Nov; 24(11):1404-7. PubMed ID: 16552972
[TBL] [Abstract][Full Text] [Related]
22. Skeletal complications and survival in renal cancer patients with bone metastases.
Woodward E; Jagdev S; McParland L; Clark K; Gregory W; Newsham A; Rogerson S; Hayward K; Selby P; Brown J
Bone; 2011 Jan; 48(1):160-6. PubMed ID: 20854942
[TBL] [Abstract][Full Text] [Related]
23. Bisphosphonates and other bone agents for breast cancer.
Wong MH; Stockler MR; Pavlakis N
Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
[TBL] [Abstract][Full Text] [Related]
24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
25. A multicenter, retrospective epidemiologic survey of the clinical features and management of bone metastatic disease in China.
Yang Y; Ma Y; Sheng J; Huang Y; Zhao Y; Fang W; Hong S; Tian Y; Xue C; Zhang L
Chin J Cancer; 2016 Apr; 35():40. PubMed ID: 27112196
[TBL] [Abstract][Full Text] [Related]
26. The influence of breast cancer subtype on bone metastases development and survival in women with metastatic breast cancer.
Piggott RP; Waters PS; Kerin MJ
Ir J Med Sci; 2017 Feb; 186(1):97-102. PubMed ID: 27734241
[TBL] [Abstract][Full Text] [Related]
27. Humeral metastasis of renal cancer: Surgical options and review of literature.
Casadei R; Drago G; Di Pressa F; Donati D
Orthop Traumatol Surg Res; 2018 Jun; 104(4):533-538. PubMed ID: 29654934
[TBL] [Abstract][Full Text] [Related]
28. Post-operative breast cancer patients diagnosed with skeletal metastasis without bone pain had fewer skeletal-related events and deaths than those with bone pain.
Koizumi M; Yoshimoto M; Kasumi F; Iwase T; Ogata E
BMC Cancer; 2010 Aug; 10():423. PubMed ID: 20704752
[TBL] [Abstract][Full Text] [Related]
29. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.
Hillner BE; Ingle JN; Berenson JR; Janjan NA; Albain KS; Lipton A; Yee G; Biermann JS; Chlebowski RT; Pfister DG
J Clin Oncol; 2000 Mar; 18(6):1378-91. PubMed ID: 10715310
[TBL] [Abstract][Full Text] [Related]
30. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
31. Is the assessment of the central skeleton sufficient for osseous staging in breast cancer patients? A retrospective approach using bone scans.
Krammer J; Engel D; Schnitzer A; Kaiser CG; Dinter DJ; Brade J; Schoenberg SO; Wasser K
Skeletal Radiol; 2013 Jun; 42(6):787-91. PubMed ID: 23287962
[TBL] [Abstract][Full Text] [Related]
32. [Clinical Analysis of Surgical treatment of long bone metastases].
Li Y; Sun Y; Shan HC; Niu XH
Zhonghua Yi Xue Za Zhi; 2016 May; 96(19):1500-4. PubMed ID: 27266495
[TBL] [Abstract][Full Text] [Related]
33. [Clinical features and prognosis in 104 colorectal cancer patients with bone metastases].
Hong RX; Lin QJ; Luo J; Dai Z; Wang WN
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):787-91. PubMed ID: 24378104
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma.
Jacobson AF; Shapiro CL; Van den Abbeele AD; Kaplan WD
Cancer; 2001 Jan; 91(1):17-24. PubMed ID: 11148555
[TBL] [Abstract][Full Text] [Related]
35. Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
Thangarajah F; Vogel C; Pahmeyer C; Eichler C; Holtschmidt J; Ratiu D; Mallmann P; Malter W
Anticancer Res; 2018 Oct; 38(10):6023-6026. PubMed ID: 30275235
[TBL] [Abstract][Full Text] [Related]
36. Comparison of skeletal segmentation by deep learning-based and atlas-based segmentation in prostate cancer patients.
Motegi K; Miyaji N; Yamashita K; Koizumi M; Terauchi T
Ann Nucl Med; 2022 Sep; 36(9):834-841. PubMed ID: 35773557
[TBL] [Abstract][Full Text] [Related]
37. Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems.
Oster G; Lamerato L; Glass AG; Richert-Boe KE; Lopez A; Chung K; Richhariya A; Dodge T; Wolff GG; Balakumaran A; Edelsberg J
Support Care Cancer; 2013 Dec; 21(12):3279-86. PubMed ID: 23884473
[TBL] [Abstract][Full Text] [Related]
38. Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.
Francini E; Montagnani F; Nuzzo PV; Gonzalez-Velez M; Alimohamed NS; Rosellini P; Moreno-Candilejo I; Cigliola A; Rubio-Perez J; Crivelli F; Shaw GK; Zhang L; Petrioli R; Bengala C; Francini G; Garcia-Foncillas J; Sweeney CJ; Higano CS; Bryce AH; Harshman LC; Lee-Ying R; Heng DYC
JAMA Netw Open; 2021 Jul; 4(7):e2116536. PubMed ID: 34292336
[TBL] [Abstract][Full Text] [Related]
39. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
40. Behavior of metastatic breast cancer according to subtype.
Van Mechelen M; Van Herck A; Punie K; Nevelsteen I; Smeets A; Neven P; Weltens C; Han S; Vanderstichele A; Floris G; Lobelle JP; Wildiers H
Breast Cancer Res Treat; 2020 May; 181(1):115-125. PubMed ID: 32193802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
